Regulatory Issues Feature Archive

What Does the CVS/Aetna Merger Mean for Primary Care?

What Does the CVS/Aetna Merger Mean for Primary Care?

Aetna will have access to data on pharmaceutical usage patterns that will give the company the opportunity to figure out who is willing to pay more for healthcare. What does this mean for patients?

Climate Change: Effects on the Incidence and Distribution of Infectious Diseases

Climate Change: Effects on the Incidence and Distribution of Infectious Diseases

Scientists warn that unless there is an adequate response and proactive measures are taken, society will soon have to deal with direct and indirect effects of the changing climate on human health.

Senator Bernie Sanders' Health Policy Advisors on Causes and Solutions to Healthcare Inequality in America

Senator Bernie Sanders' Health Policy Advisors on Causes and Solutions to Healthcare Inequality in America

Healthcare disparities have increased along with widening economic inequality between wealthy and low-income Americans.

Data Transparency and Publication Bias: Impact on Clinical Trials

Data Transparency and Publication Bias: Impact on Clinical Trials

The need for data transparency carries an ethical and moral obligation and requires nonselective and unbiased publication of clinical results.

New Part B Drug Rule May Lead to Steep Payment Reductions for Specialists

New Part B Drug Rule May Lead to Steep Payment Reductions for Specialists

The Centers for Medicare & Medicaid Services has issued a final rule that could result in steep payment reductions for physicians of certain specialties in 2018.

Reducing the P-Value for Statistical Significance to Improve the Quality of Research?

Reducing the P-Value for Statistical Significance to Improve the Quality of Research?

In a controversial and divisive article, a group of researchers proposes to improve "statistical standards of evidence" by lowering the P value from P <.05 to P <.005 in the fields of biomedical and social sciences.

MACRA: Five Things You Should Know

MACRA: Five Things You Should Know

Here are five potentially pivotal MACRA issues that you should know about.

CAR T Cell Therapy for Acute Lymphoblastic Leukemia Recommended by FDA

CAR T Cell Therapy for Acute Lymphoblastic Leukemia Recommended by FDA

The FDA recommended the approval of CTL019 chimeric antigen receptor (CAR) T cell therapy for acute lymphoblastic leukemia (ALL).

A Deeper Look Into the Flu Vaccine and Its Importance to Public Health

A Deeper Look Into the Flu Vaccine and Its Importance to Public Health

If flu vaccines were mandatory for all school-age children, the savings on direct healthcare costs alone would easily reach into the tens of millions.

Threats Posed by Congressional Acts to National Health Initiatives

Threats Posed by Congressional Acts to National Health Initiatives

Passage of the Consolidated Appropriations Act and of the AHCA leaves large holes in the funding of the proposed national approach to infectious disease control.

Reasons Why the Affordable Care Act is Wrongly Blamed for Increased Premiums

Reasons Why the Affordable Care Act is Wrongly Blamed for Increased Premiums

If the employer's plan is deemed unaffordable, families and individuals now have the ability to purchase insurance at a lower cost through the ACA marketplace.

Concerns Over The American Health Care Act

Concerns Over The American Health Care Act

On May 4, 2017, the House of Representatives passed the American Health Care Act by a narrow margin, even though the Congressional Budget Office had not officially reviewed and reported on the bill's impact.

Direct-to-Consumer Genomic Testing Pros and Cons: Q&A

Direct-to-Consumer Genomic Testing Pros and Cons: Q&A

Cancer Therapy Advisor asked Dr Roberts about the PGen Study and the implications for DTC cancer risk testing in the future.

Health Law Expert on the Current State of Medical Malpractice: a Q&A

Health Law Expert on the Current State of Medical Malpractice: a Q&A

As US citizens continue to adjust to the changing political landscape, many in the medical field are wondering whether now may be the right time for medical malpractice reform.

New Bill to Tackle Antibiotic Resistance

New Bill to Tackle Antibiotic Resistance

Congress will now be addressing the problem of antibiotic resistance with a bill introduced to the US House of Representatives on March 30, 2017.

Improving Care for Medicaid Consumers Under the ACA

Improving Care for Medicaid Consumers Under the ACA

The challenges to providing optimal levels of healthcare for people using Medicaid systems are many-fold.

Senator Cruz's Arguments on the Affordable Care Act

Senator Cruz's Arguments on the Affordable Care Act

On February 7, 2017, CNN hosted an interesting debate between Bernie Sanders, Independent senator of Vermont, and Ted Cruz, Republican senator from Texas, regarding the future of the Affordable Care Act.

National Academies Report on Health Effects of Cannabis

National Academies Report on Health Effects of Cannabis

In January 2017, the National Academies of Sciences, Engineering, and Medicine released a report titled "The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendation for Research."

What the FDA Can Do to Help Bring Improved Pain Medicines to the Market

What the FDA Can Do to Help Bring Improved Pain Medicines to the Market

Dr Katz formulated 10 recommendations for the FDA, 3 of which he detailed during his presentation.

The Issues With Clinical Studies That Impede the Development of New Pain Drugs

The Issues With Clinical Studies That Impede the Development of New Pain Drugs

Drug development faces 2 major issues: pre-clinical animal efficacy studies do not accurately predict human efficacy, and clinical trials often wrongly fail to show drug efficacy.

Are Public-Private Partnerships the Answer to the Aging Biomedical Workforce?

Are Public-Private Partnerships the Answer to the Aging Biomedical Workforce?

Promoting public-private partnerships to maximize resources, knowledge-sharing, and expediency in treatment development, as a way to attract emerging and established researchers.

Opinion: Why ICD-10 Will Do More Bad Than Good

Opinion: Why ICD-10 Will Do More Bad Than Good

Steven Croft, MD, lays down his reasons why ICD-10 will do more bad than good for physician and patient communities.

Pain Management During Pregnancy Warrants Special Consideration

Pain Management During Pregnancy Warrants Special Consideration

Opioid use in women of reproductive-age has been a hot topic in the news of late.

Patients in Pain Need Compassion, Not Regulations

Patients in Pain Need Compassion, Not Regulations

It is imperative that the United States finds more effective ways to deal with the growing availability and utilization of opiates and other drugs for pain that is compassionate and grounded in medicine.

Sign Up for Free e-Newsletters